Loading...
Dear E, I am pleased to announce the speaker lineup for the FierceBiotech Executive Breakfast & Panel Discussions during the J.P. Morgan Annual Healthcare Conference on January 14th in San Francisco. This year's event will feature a full breakfast buffet, two panel discussions, coffee break, and an Ask the Experts Closing Reception. Seats are limited and expected to sell out. Early Bird Rates end tomorrow, December 13th - click here to register and reserve your spot at the event. Panel One / Strategic Considerations for the Commercialization of Cell and Gene Therapies: Dr. Mitchell Finer / Chief Scientific Officer / ElevateBio David J. Lennon, Ph.D. / President / AveXis, a Novartis Company Paul Levesque / Global President of Pfizer Rare Disease / Pfizer Opening Remarks: Keiko Oishi / President and COO / CMIC Alberto Santagostino / Head of Cell and Gene Technologies / Lonza Closing Remarks: Stephen J. Ubl / President and Chief Executive Officer / PhRMAPanel Two / The Promise of AI: Can Artificial Intelligence and Machine Learning Really Transform R&D? I look forward to seeing you in San Francisco. Best, Rebecca Willumson |
Click here to unsubscribe or to manage your subscriptions. ©2019 FierceMarkets, a division of Questex, LLC. All rights reserved. 1900 L St NW | Washington, DC | 20036 www.questex.com |
Loading...
Loading...